Mutations Position Table
PSEN1 E184 Mutations
| Mutation | Pathogenicity | DNA Change | Expected RNA | Protein Consequence | Coding/Non-Coding | Genomic Region | Neuropathology | Biological Effect | Primary Papers |
|---|---|---|---|---|---|---|---|---|
| E184D |
AD : Pathogenic, DLB : Not Classified, PPA : Not Classified | Substitution | Substitution | Missense | Coding | Exon 7 | Neuropathology consistent with AD in three cases. In addition, CAA pathology described in two cases. Also, in two cases, robust Lewy body pathology and, in one of these cases, accumulation of the non-Aβ component of AD amyloid (NAC) in plaques and astrocytes. |
Increased Aβ42/Aβ40 ratio; reduced Aβ37/Aβ42 ratio in cultured cells. |
Yasuda et al., 1997 |
| E184G |
AD : Likely Pathogenic | Substitution | Splicing Alteration | Missense | Coding | Exon 7 | Unknown, but MRI of one patient revelaed global cortical atrophy. |
Increased Aβ42/Aβ40 ratio, with decreased Aβ42 and Aβ40 production in vitro. In silico algorithms predicted the mutation is damaging and causes structural alterations. Also, mutation is near splice site. |
Wallon et al., 2012 |
Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.